Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon May 26, 2021 11:04am
71 Views
Post# 33267543

RE:RE:RE:OTCQB

RE:RE:RE:OTCQB57 cents a share is insane but yet this is where we sit and if we have the manipulator shorts to thank for it then they are really good at their job and yet they continue to try and keep it down.  I dont understand its like they want it to go lower and lower and lower.  Thats all fine and dandy but what if they accomplish their goal so well that it never goes back up.  Now would be the time to pump this thing back up yet there is no push to do that.  Over 60% down and they want more down?  WTF

The only way we reach 88 cents again is if Tripp can deliever and he has to deliever in revenue from Aristotle.  Its good we are making money on aristotle today but in the short term there is more room for this to go lower and that what must be the shorters are thinking as well.

1. Covid revenue decreased in Q1 even though Q1 should had been better than Q4.  In Q4 they had the last 2 weeks of Decemeber off.  In Q1 they had no time off and one would had thought covid testing would had increased after the holidays.  This would conclude that Q2 covid revenue will be lower again. Not by a huge margin but revenue from covid migth start with a 1 instead of a 2.
2. Increasing costs due to marketing for aristotle and any other costs associated with it and these costs will be massive.  That "war chest" will be depleted quickly
3. More shares will be released for the purchase of Health Clinics

All I see for the rest of this year is downward pressure on the SP due to the steps needed to get Aristotle to its full potential by next year.

If someone has other ideas of why they can hold this level or increase then please share them.  The only thing that I see that would accomplish that is one of the 3.
1. Quicker than expected revenue from aristotle.  Enough revenue to make up the difference in decreased covid testing
2. Signing with a large health care provider not just mentioning "large health care provider" in an interview
3. Covid testing agreement with large airlines on their international trips.

Listing on a US exchange is good but we got to $1.60 without having that so I dont see that being our catalyst to change in the short term.
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse